Literature DB >> 8619771

Referral patterns of uveitis in a tertiary eye care center.

A Rodriguez1, M Calonge, M Pedroza-Seres, Y A Akova, E M Messmer, D J D'Amico, C S Foster.   

Abstract

OBJECTIVE: To analyze the referral patterns and diagnosis of uveitis during the past decade in a large tertiary eye center.
DESIGN: The records of 1237 patients with uveitis referred to the Immunology Service of the Massachusetts Eye and Ear Infirmary from 1982 to 1992 were classified and analyzed. Data regarding sex, race, nationality, referral site, ages at presentation and onset of uveitis, ocular involvement, clinical characteristics, ocular condition, and systemic disease associations were obtained.
RESULTS: The mean age at onset of uveitis was 37.2 years; the male-to-female ratio was 1:1.4. Most patients were white (85.8%), born in the United States (83.1%), and referred from within New England (84.7%). Anterior uveitis was most common (51.6%), followed by posterior uveitis (19.4%), panuveitis (16.0%), and intermediate uveitis (13.0%). Chronic (58.3%), nongranulomatous (77.7%), and noninfectious (83.1%) were the most frequent types of uveitis. The most common entities included idiopathic (34.9%), seronegative spondyloarthropathies (10.4%), sarcoidosis (9.6%), juvenile rheumatoid arthritis (5.6%), systemic lupus erythematosus (4.8%), Behçet's disease (2.5%), and the acquired immunodeficiency syndrome (2.4%).
CONCLUSION: The appearance of new uveitic entities, such as the acute retinal necrosis syndrome, multifocal choroiditis and panuveitis, birdshot retinochoroidopathy, and acquired immunodeficiency syndrome-related uveitis, and the reemergence of the classic infectious causes of uveitis, tuberculosis and syphilis, have changed the way we approach the diagnosis and management of posterior and panuveitis at the Massachusetts Eye and Ear Infirmary.

Entities:  

Mesh:

Year:  1996        PMID: 8619771     DOI: 10.1001/archopht.1996.01100130585016

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  84 in total

1.  Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device.

Authors:  Ryan B Rush; Debra A Goldstein; David G Callanan; Beeran Meghpara; William J Feuer; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2011-02-01       Impact factor: 5.258

2.  Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.

Authors:  Allison R Loh; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2010-10       Impact factor: 5.258

Review 3.  Ocular Sarcoidosis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Clin Chest Med       Date:  2015-12       Impact factor: 2.878

4.  Uveitis and neurologic diseases: an often overlooked relationship.

Authors:  Saskia M Maca; Martina Scharitzer; Talin Barisani-Asenbauer
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

5.  Transvitreal migration of a Toxocara larva resulting in a second chorioretinal granuloma.

Authors:  Dhashani Sivaratnam; Visvaraja Subrayan; Nadir A Ali
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

6.  Clinical patterns and characteristics of uveitis in a secondary hospital in southern China.

Authors:  Yang Zheng; Li-Xin Zhang; Qian-Li Meng; Min Zhang; Ying Cui; Qing-Yang Liu; Zhong-Ling Luo; Li-Ping Du
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 7.  Uveitis in the elderly--is it easy to identify the masquerade?

Authors:  P Zamiri; S Boyd; S Lightman
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

8.  Patterns of Laboratory Testing Utilization Among Uveitis Specialists.

Authors:  Cecilia S Lee; Sandeep Randhawa; Aaron Y Lee; Deborah L Lam; Russell N Van Gelder
Journal:  Am J Ophthalmol       Date:  2016-08-10       Impact factor: 5.258

9.  Reclassifying Idiopathic Uveitis: Lessons From a Tertiary Uveitis Center.

Authors:  Rene Y Choi; Erick Rivera-Grana; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2018-10-22       Impact factor: 5.258

10.  Infectious Uveitis.

Authors:  Phoebe Lin
Journal:  Curr Ophthalmol Rep       Date:  2015-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.